Off balance: Interferons in COVID-19 lung infections
Open Access
- 19 October 2021
- journal article
- review article
- Published by Elsevier in EBioMedicine
- Vol. 73, 103642
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2020/07040-1)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (305430/2019-0)
- Fundação Butantan
This publication has 71 references indexed in Scilit:
- Endothelial Cell Activation and Proliferation Modulate NKG2D Activity by Regulating MICA Expression and SheddingJournal of Innate Immunity, 2013
- Systematic identification of type I and type II interferon-induced antiviral factorsProceedings of the National Academy of Sciences, 2012
- The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon at the Level of the MAVS Adaptor ProteinPLOS Pathogens, 2011
- Host Defense Pathways: Role of Redundancy and Compensation in Infectious Disease PhenotypesImmunity, 2011
- Influenza Virus Non-Structural Protein 1 (NS1) Disrupts Interferon SignalingPLOS ONE, 2010
- Influenza A Virus Polymerase Inhibits Type I Interferon Induction by Binding to Interferon β Promoter Stimulator 1Journal of Biological Chemistry, 2010
- Regulation of Interferon‐γ During Innate and Adaptive Immune Responses2007
- Influenza Virus Evades Innate and Adaptive Immunity via the NS1 ProteinJournal of Virology, 2006
- Production of type I interferonsJournal of Experimental Medicine, 2005
- Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infectionJournal of Experimental Medicine, 2005